SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001587221-22-000030
Filing Date
2022-05-13
Accepted
2022-05-13 16:12:42
Documents
72
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q zsan-20220331.htm   iXBRL 10-Q 1326421
2 EX-10.6 exhibit106-harrohofligerpo.htm EX-10.6 932
3 EX-31.1 exhibit311q1-202210q.htm EX-31.1 9706
4 EX-31.2 exhibit312q1-202210q.htm EX-31.2 9623
5 EX-32.1 exhibit321q1-202210q.htm EX-32.1 8887
11 GRAPHIC image.jpg GRAPHIC 119022
  Complete submission text file 0001587221-22-000030.txt   5802541

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zsan-20220331.xsd EX-101.SCH 49083
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT zsan-20220331_cal.xml EX-101.CAL 58347
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zsan-20220331_def.xml EX-101.DEF 219396
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zsan-20220331_lab.xml EX-101.LAB 523642
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zsan-20220331_pre.xml EX-101.PRE 341859
66 EXTRACTED XBRL INSTANCE DOCUMENT zsan-20220331_htm.xml XML 726632
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Filer) CIK: 0001587221 (see all company filings)

IRS No.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36570 | Film No.: 22922843
SIC: 2834 Pharmaceutical Preparations